Abstract
Estrogen-dependent breast cancer (EDBC) is a kind of common malignant tumor in postmenopausal women with growing tendency in recent years. Aromatase (AR) is the key enzyme responsible for estrogen biosynthesis and has been considered as an important target for designing inhibitors as potent therapeutic agents for EDBC. AR inhibitors (AIs) are divided into steroidal and nonsteroidal compounds, and the latter shows high inhibitory potency against AR. This review summarizes recent advancement in nonsteroidal AIs.
Keywords: Estrogen-dependent breast cancer, postmenopausal women, aromatase, aromatase inhibitors, nonsteroida, Nonsteroidal Aromatase Inhibitors, Aromatase (AR), therapeutic agents, nonsteroidal, peripheral tissues, endocrine therapy, multienzymatic complex, granulosa, luteal cells, glycosylated cytochrome P450, C19 androgenic, ovarian granulosa cells, prostaglandin E2 (PGE2), cellular transformation, oncogenesis, inflammatory cytokines, (EGFR) HER-2, COX-2, PGE2, CYP19, letrozole, anastrozole, tolerability, mammary tumors, long-term tamoxifen treatment, traditional Chinese medicine, flavanone, liquiritigenin, inhibitory potency, pyridinecontaining (E)-isomer, aminoglutethimide, Isoflavones, prostate cancer, imidazolic, Dual Aromatase-Sulfatase Inhibitors, Estrone 3-sulfamate (EMATE), YM511, Nimesulide Analogues, breast adipose stromal, celecoxib, Estrogen receptor
Current Medicinal Chemistry
Title: Recent Advancement in Nonsteroidal Aromatase Inhibitors for Treatment of Estrogen-Dependent Breast Cancer
Volume: 17 Issue: 30
Author(s): J. Jiao, H. Xiang and Q. Liao
Affiliation:
Keywords: Estrogen-dependent breast cancer, postmenopausal women, aromatase, aromatase inhibitors, nonsteroida, Nonsteroidal Aromatase Inhibitors, Aromatase (AR), therapeutic agents, nonsteroidal, peripheral tissues, endocrine therapy, multienzymatic complex, granulosa, luteal cells, glycosylated cytochrome P450, C19 androgenic, ovarian granulosa cells, prostaglandin E2 (PGE2), cellular transformation, oncogenesis, inflammatory cytokines, (EGFR) HER-2, COX-2, PGE2, CYP19, letrozole, anastrozole, tolerability, mammary tumors, long-term tamoxifen treatment, traditional Chinese medicine, flavanone, liquiritigenin, inhibitory potency, pyridinecontaining (E)-isomer, aminoglutethimide, Isoflavones, prostate cancer, imidazolic, Dual Aromatase-Sulfatase Inhibitors, Estrone 3-sulfamate (EMATE), YM511, Nimesulide Analogues, breast adipose stromal, celecoxib, Estrogen receptor
Abstract: Estrogen-dependent breast cancer (EDBC) is a kind of common malignant tumor in postmenopausal women with growing tendency in recent years. Aromatase (AR) is the key enzyme responsible for estrogen biosynthesis and has been considered as an important target for designing inhibitors as potent therapeutic agents for EDBC. AR inhibitors (AIs) are divided into steroidal and nonsteroidal compounds, and the latter shows high inhibitory potency against AR. This review summarizes recent advancement in nonsteroidal AIs.
Export Options
About this article
Cite this article as:
Jiao J., Xiang H. and Liao Q., Recent Advancement in Nonsteroidal Aromatase Inhibitors for Treatment of Estrogen-Dependent Breast Cancer, Current Medicinal Chemistry 2010; 17 (30) . https://dx.doi.org/10.2174/092986710792927877
DOI https://dx.doi.org/10.2174/092986710792927877 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Development of <sup>18</sup>F-Labeled PET Probes for Imaging Cell Proliferation
Current Topics in Medicinal Chemistry Stimuli-responsive Drug Delivery Nanosystems: From Bench to Clinic
Current Nanomedicine Modified Nucleosides That Can Be Incorporated into DNA Enzymatically or in Live Cells
Current Organic Chemistry They Must Hold Tight: Junction Proteins, Microbiota And Immunity In Intestinal Mucosa
Current Protein & Peptide Science Proline Oxidase (POX) as A Target for Cancer Therapy
Current Drug Targets Performance of Feature Selection Methods
Current Genomics Expression and Function of the Endocannabinoid System in Glial Cells
Current Pharmaceutical Design Recent Developments in Chimeric NSAIDs as Anticancer Agents: Teaching an Old Dog a New Trick
Mini-Reviews in Medicinal Chemistry Oxaliplatin-mediated Inhibition of Survivin Increases Sensitivity of Head and Neck Squamous Cell Carcinoma Cell Lines to Paclitaxel
Current Cancer Drug Targets Liposomal Drug Delivery System for Cancer Therapy: Advancement and Patents
Recent Patents on Drug Delivery & Formulation Recent Advancemnts in Biodegradable Ocular Implants
Current Drug Delivery Physiology and Pharmacology of the Vanilloid Receptor
Current Neuropharmacology Role of CHK2 Inhibitors in the Cellular Responses to Ionizing Radiation
Mini-Reviews in Medicinal Chemistry Synthesis and Antitumor Activity of Novel N-Benzoyl-N'-substituted Pyrimidinyl (Thio)semicarbazide Derivatives
Letters in Drug Design & Discovery The Significance of Meat in the Diet
Current Nutrition & Food Science Obesity and Arterial Compliance Alterations
Current Vascular Pharmacology Exploring Single Nucleotide Polymorphisms in ITGAV for Gastric, Pancreatic and Liver Malignancies: An Approach Towards the Discovery of Biomarker
Combinatorial Chemistry & High Throughput Screening Targeting Tumor Necrosis Factor Alpha for Alzheimer’s Disease
Current Alzheimer Research The CLCA Gene Family: Putative Therapeutic Target for Respiratory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Docking and Virtual Screening to Identify PKC Agonists: Potentials in Anticancer Therapeutics
Current Computer-Aided Drug Design